Sign In | 0 items - USD $0.00 | Search | 简体中文

Products Content

Blog

Characterizing Pathogenic Protein Aggregates for Utilization as Molecular Tools to Accelerate Neurodegenerative Disease Research

Webinar: Accelerating Neurodegenerative Disease Research with Pathogenic Protein Aggregates

Brenda Knox | September 14th, 2021 | Webinar

Wild Type SOD1 in ALS

The Role of Wild Type SOD1 in ALS

Brenda Knox | September 1st, 2021 | Scientific Review

Targeting Alpha Synuclein Aggregation with CBP/p300 Inhibitors: A Novel Approach in Parkinson’s Disease Therapeutics

Christina Korgiopoulou | August 13th, 2021 | Product Citation Reviews

9th Annual Neuroscience Virtual Conference

9th Annual Neuroscience Virtual Conference

Brenda Knox | August 4th, 2021 | Conferences

Tau Monomers

Targeting Tau Monomers: Potential for Therapeutic Interventions

Brenda Knox | June 28th, 2021 | Scientific Review

Why target Alpha Synuclein Monomers?

Alpha Synuclein Monomers: Why Target Them?

Brenda Knox | June 10th, 2021 | Scientific Review

N terminal acetylated alpha synuclein monomers and fibrils for neurodegenerative disease research

N-terminal Acetylated Alpha Synuclein in Parkinson’s Disease

StressMarq Biosciences | May 13th, 2021 | Scientific Review

Tau causes astrocyte senescence in neurodegenerative disease

Tau Induces Astrocyte Senescence in Alzheimer’s Disease

StressMarq Biosciences | April 26th, 2021 | Product Citation Reviews

Stressmarq's tau preformed fibrils were used to study the effects of polyamine on tau oligomerization, seeding and aggregation

How Polyamines Affect Tau Aggregation in Alzheimer’s Disease

StressMarq Biosciences | April 15th, 2021 | Product Citation Reviews

Sonication of Alpha Synuclein Fibrils for Neurodegenerative Research

StressMarq Video: Why Do We Sonicate Our Pre-formed Fibrils?

StressMarq Biosciences | April 8th, 2021 | Video